Share

COVID-19: Will a vaccine mean a return to normal life?

The race for a COVID-19 vaccine is getting tighter, with Moderna and Pfizer leading the way. Moderna announced that its candidate is 94.5 per cent effective, with Pfizer last week reporting 90 per cent efficacy for its candidate. These two have certainly raised the bar. Joining CNBC Africa for an analysis of the vaccine developments is Michael Breen, Director of Infectious Diseases and Ophthalmology at GlobalData.
Tue, 17 Nov 2020 16:34:19 GMT